LEXARIA BIOSCIENCE CORP. Increase (Decrease) in Accounts Payable
LEXARIA BIOSCIENCE CORP. (LEXX) reported Increase (Decrease) in Accounts Payable of -$1.89 thousand for the 6-month period ending 2014-04-30, per its 10-Q filed 2014-06-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2014-06-12
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable for the quarter ending 2014-04-30 was -$51.84K, a 428.53% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable for the quarter ending 2014-01-31 was $49.96K, a 504.59% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable for the quarter ending 2013-10-31 was $39.84K, a 53.14% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable for the quarter ending 2013-07-31 was $5.34K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable for fiscal 2013 was $69.23K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable for fiscal 2012 was -$55.27K, a 129.90% decline from fiscal 2011.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable for fiscal 2011 was $184.88K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in accounts payable for fiscal 2010 was -$61.81K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2014-04-30 | -$51.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12 | -$1.89K 10-Q · filed 2014-06-12 | $37.96K derived: sum of 3 quarters · filed 2014-06-12 | $43.30K derived: sum of 4 quarters · filed 2014-06-12 |
| 2014-01-31 | $49.96K 10-Q · filed 2014-03-12 | $89.80K derived: sum of 2 quarters · filed 2014-03-12 | $95.14K derived: sum of 3 quarters · filed 2014-03-12 | $110.92K derived: sum of 4 quarters · filed 2014-06-12 |
| 2013-10-31 | $39.84K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24 | $45.19K derived: sum of 2 quarters · filed 2014-01-24 | $60.97K derived: sum of 3 quarters · filed 2014-06-12 | $69.23K 10-K · filed 2014-01-24 |
| 2013-07-31 | $5.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-10 | $21.12K derived: sum of 2 quarters · filed 2014-06-12 | $29.39K 10-Q · filed 2013-09-10 | $114.42K derived: sum of 4 quarters · filed 2014-06-12 |
| 2013-04-30 | $15.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12 | $24.04K 10-Q · filed 2014-06-12 | $109.08K derived: sum of 3 quarters · filed 2014-06-12 | $94.04K derived: sum of 4 quarters · filed 2014-06-12 |
| 2013-01-31 | $8.26K 10-Q · filed 2014-03-12 | $93.30K derived: sum of 2 quarters · filed 2014-03-12 | $78.25K derived: sum of 3 quarters · filed 2014-03-12 | $153.23K derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-10-31 | $85.03K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24 | $69.99K derived: sum of 2 quarters · filed 2014-01-24 | $144.97K derived: sum of 3 quarters · filed 2014-01-24 | -$55.27K 10-K · filed 2014-01-24 |
| 2012-07-31 | -$15.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-10 | $59.94K derived: sum of 2 quarters · filed 2013-09-10 | -$140.30K 10-Q · filed 2013-09-10 | $89.69K derived: sum of 4 quarters · filed 2013-09-10 |
| 2012-04-30 | $74.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-06-12 | -$125.26K 10-Q · filed 2013-06-12 | $104.73K derived: sum of 3 quarters · filed 2013-06-12 | $96.44K derived: sum of 4 quarters · filed 2013-06-12 |
| 2012-01-31 | -$200.24K 10-Q · filed 2013-03-13 | $29.75K derived: sum of 2 quarters · filed 2013-03-13 | $21.46K derived: sum of 3 quarters · filed 2013-03-13 | -$45.01K derived: sum of 4 quarters · filed 2013-03-13 |
| 2011-10-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $221.70K derived: sum of 2 quarters · filed 2013-01-29 | $155.23K derived: sum of 3 quarters · filed 2013-01-29 | $184.88K 10-K · filed 2013-01-29 |
| 2011-07-31 | -$8.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-12 | -$74.76K derived: sum of 2 quarters · filed 2012-09-12 | -$45.12K 10-Q · filed 2012-09-12 | -$151.87K derived: sum of 4 quarters · filed 2012-09-12 |
| 2011-04-30 | -$66.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-07 | -$36.82K 10-Q · filed 2012-06-07 | -$143.57K derived: sum of 3 quarters · filed 2012-06-07 | |
| 2011-01-31 | $29.64K 10-Q · filed 2012-03-13 | -$77.10K derived: sum of 2 quarters · filed 2012-03-13 | ||
| 2010-10-31 | -$106.75K derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | -$61.81K 10-K · filed 2012-01-30 | ||
| 2010-07-31 | $44.93K 10-Q · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |